Cargando…
1630. Clinical Profile of Acute Respiratory Illness (ARI) Events in the Phase 3 Trial The RSV Vaccine Efficacy Study iN Older Adults Immunized against RSV Disease (RENOIR)
BACKGROUND: RENOIR is a phase 3 randomized, double-blinded, placebo-controlled study evaluating Vaccine Efficacy (VE) to prevent lower respiratory tract illness (LRTI) in adults ≥ 60 years of age during 2 RSV seasons in Northern and Southern Hemisphere countries (NCT05035212). End of RSV Season 1 (E...
Autores principales: | Marc, Gonzalo Pérez, Walsh, Edward E, DeHaan, Elliot N, Llapur, Conrado J, Zareba, Agnieszka, Jiang, Qin, Ilangovan, Kumar, Woodside, John, Eiras, Daniel P, Mikati, Tarek, Kalinina, Elena, Cooper, David, Anderson, Annaliesa S, Swanson, Kena A, Gruber, William C, Gurtman, Alejandra C, Schmoele-Thoma, Beate |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677814/ http://dx.doi.org/10.1093/ofid/ofad500.1464 |
Ejemplares similares
-
1634. Respiratory Syncytial Virus-Associated Health Care Utilization in the Pivotal Phase 3 Trial RSV Vaccine Efficacy Study In Older Adults Immunized Against RSV Disease (RENOIR)
por: Walsh, Edward E, et al.
Publicado: (2023) -
1632. Bivalent RSV Prefusion F-Based Subunit Vaccine Generates High Neutralizing Titers in Older Adults
por: Fukushima, Yasushi, et al.
Publicado: (2023) -
2781. Statistical Modeling to Predict Maternal RSV Vaccine Efficacy from Neutralizing Titers
por: Cai, Bing, et al.
Publicado: (2019) -
2755. Phase 1/2, First-in-Human Study of the Safety, Tolerability, and Immunogenicity of an RSV Prefusion F-Based Subunit Vaccine Candidate
por: Schmoele-Thoma, Beate, et al.
Publicado: (2019) -
Renoir
por: Hayes, Colin
Publicado: (1967)